切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2011, Vol. 05 ›› Issue (02) : 157 -162. doi: 10.3877/cma.j.issn.1674-0793.2011.02.019

所属专题: 文献

循证医学

结直肠癌肝转移灶首次切除和复发后第二次切除对比的Meta分析
姜慧员1, 梁小波2,(), 侯生槐2, 胡学忠2, 李超亿2, 马俊杰2   
  1. 1. 030001 太原,山西医科大学第二临床医学院普外科
    2. 山西省肿瘤医院结直肠肛门外科
  • 收稿日期:2010-11-30 出版日期:2011-04-01
  • 通信作者: 梁小波

Meta-analysis of clinical outcome and safety of repeat hepatectomy versus first hepatectomy for patient with live metastases from colorectal cancer

Hui-yuan JIANG1, Xiao-bo LIANG2,(), Sheng-huai HOU2, Xue-zhong HU2, Chao-yi LI2, Jun-jie MA2   

  1. 1. Department of General Surgery, the Second Medical College, Shanxi Medical University, Taiyuan 030001, China
  • Received:2010-11-30 Published:2011-04-01
  • Corresponding author: Xiao-bo LIANG
  • About author:
    Corresponding author: LIANG Xiao-bo, Email:
引用本文:

姜慧员, 梁小波, 侯生槐, 胡学忠, 李超亿, 马俊杰. 结直肠癌肝转移灶首次切除和复发后第二次切除对比的Meta分析[J/OL]. 中华普通外科学文献(电子版), 2011, 05(02): 157-162.

Hui-yuan JIANG, Xiao-bo LIANG, Sheng-huai HOU, Xue-zhong HU, Chao-yi LI, Jun-jie MA. Meta-analysis of clinical outcome and safety of repeat hepatectomy versus first hepatectomy for patient with live metastases from colorectal cancer[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2011, 05(02): 157-162.

目的

比较结直肠癌肝转移灶首次切除和复发后第二次切除临床疗效和安全性。

方法

检索1992年1月至2010年6月间发表的有关结直肠癌肝转移灶首次切除和复发后第二次切除对比的研究,按纳入和排除标准筛选后质量评分,提取临床效应指标,进行Meta分析。

结果

22篇文献共计3750病例入选本次Meta分析。较之首次切除,复发后第二次切除手术时间增加平均39 min(P<0.00001,95% CI=-65.21~-23.13);术中输血量增加1.1 U(P<0.00001,95% CI=-1.75~-0.79)。术后ICU住院时间,术后失血及术后住院时间差异没有统计学意义。术后总并发症发生率及具体并发症发生率、远期疗效1年、3年、5年生存率、无瘤生存期及复发率差异没有统计学意义。

结论

与结直肠肝转移灶首次切除比较,复发后第二次切除具有其相似的手术安全性和有效性。复发后手术切除为首选方案,但是为了获得更有效的远期疗效,应进一步考虑综合治疗。

Objective

To compare clinical outcomes and safety of repeat hepatectomy for patients with liver metastases from colorectal cancer with those of a first liver resection.

Methods

The literature was searched for all studies reported on repeat hepatectomy versus a first liver resection patients with liver metastases from colorectal cancer between January 1992 to June 2010. According to inclusion and exclusion criteria, the clinical data were extracted. Trials were assessed using the modified Newcastle-Ottawa Score. Analysis were performed by RevMan 4.2.

Results

Twenty-two clinical studies were included in our systematic reviews. Compared with the first liver resection group, operation time of the repeat hepatectomy group was longer by 39 minutes[95% CI(-65.21, -23.13), P<0.00001], intraoperatie blood transfusions was longer by 1.1 U [95% CI(-1.75, -0.79), P<0.00001]. There were no significant differences in the number of patient of length of intensive care unit stay, blood loss, length of hospitalization. There were no significant differences in the morbidity rate of post-operation complications, 1,3,5-year overall survival, disease-free surial, the incidence of recurrence between the two groups.

Conclusions

Repeat hepatectomy for patients with colorectal cancer metastases is safe and provides survival benefit equal to that of a first liver resection. Repeat hepatectomy is first selection scheme, but in order to get a more effective long-term outcome, further consider comprehensive treatment should be considered.

图1 手术持续时间的固定效应模型的优势比图
图2 术中输血量的固定效应模型的优势比图
表1 纳入研究病例手术数据分析
表2 纳入研究病例术后总并发症、具体并发症及术后死亡率数据分析
表3 纳入研究病例术后复发率及远期疗效数据分析
图3 手术持续时间的漏斗图
图4 术中输血量的漏斗图
1
Mise Y, Imamura H, Hashimoto T, et al. Cohort study of the survival benefit of resection for recurrent hepatic and/or pulmonary metastases after primary hepatectomy for colorectal metastases. Ann Surg, 2010, 251(5): 902-909.
2
Yamamoto J, Kosuge T, Shimada K, et al. Repeat liver resection for recurrent colorectal liver metastases. Am J Surg, 1999, 178(4): 275-281.
3
Shaw IM, Rees M, Welsh FK, et al. Repeat hepatic resection for recurrent colorectal liver metastases is associated with favorable long-term survival. Br J Surg, 2006, 93(4): 457-464.
4
Pessaux P, Lermite E, Brehant O, et al. Repeat hepatectomy for recurrent colorectal liver metastases. J Surg Oncol, 2006, 93(1): 1-7.
5
Brachet D, Lermite E, Rouquette A, et al. Prognostic factors of survival in repeat liver resection for recurrent colorectal metastases: review of sixty-two cases treated at a single institution. Dis Colon Rectum, 2009, 52(3): 475-483.
6
Athanasiou T, Al-Ruzzeh S, Kumar P, et al. Off-pump myocardial reva scularization is associated with less incidence of stroke in elderly patients. Ann Thorac Surg, 2004, 77(2): 745-753.
7
Adam R, Pascal G, Castaing D, et al. Tumor progression while on chem otherapy: a contraindication to liver resection for multiple colorectal metastases?. Ann Surg, 2004(6): 1052-1061.
8
Kin T, Nakajima Y, Kanehiro H, et al. Repeat hepatectomy for recurrent colorectal metastases. World J Surg, 1998(10): 1087-1091.
9
Chiappa A, Zbar AP, Biella F, et al. Survival after repeat hepatic resection for recurrent colorectal metastases. Hepatogastroenterology, 1999, 46(26): 1065-1070.
10
Suzuki S, Sakaguchi T, Yokoi Y, et al. Impact of repeat hepatectomy on recurrent colorectal liver metastases. Surgery, 2001, 129(4): 421-428.
11
Sugawara G, Isogai M, Kaneoka Y, et al. Repeat hepatectomy for recurrent colorectal metastases. Surg Today, 2005, 35(4): 282-289.
12
Ahmad A, Chen SL, Bilchik AJ. Role of repeated hepatectomy in the multimodal treatment of hepatic colorectal metastases. Arch Surg, 2007, 142(6): 526-531.
13
Yamada H, Katoh H, Kondo S, et al. Repeat hepatectomy for recurrent hepatic metastases from colorectal cancer. Hepatogastroenterology, 2001, 48(39): 828-830.
14
Takahashi S, Inoue K, Konishi M, et al. Prognostic factors for poor survival after repeat hepatectomy in patients with colorectal liver metastases. Surgery, 2003, 133(6): 627-634.
15
Tanaka K, Shimada H, Ohta M, et al. Procedures of choice for resection of primary and recurrent liver metastases from colorectal cancer. World J Surg, 2004, 28(5): 482-427.
16
Sa Cunha A, Laurent C, Rault A, et al. A second liver resection due to recurrent colorectal liver metastases. Arch Surg, 2007, 142(12): 1144-1149.
17
Bozzetti F, Bignami P, Montalto F, et al. Repeated hepatic resection for recurrent metastases from colorectal cancer. Br J Surg, 1992, 79(2): 146-148.
18
Pinson CW, Wright JK, Chapman WC, et al. Repeat hepatic surgery for colorectal cancer metastasis to the liver. Ann Surg, 1996, 223(6): 765-773.
19
Adam R, Bismuth H, Castaing D, et al. Repeat hepatectomy for colorectal liver metastases. Ann Surg, 1997, 225(1): 51-60.
20
Chu QD, Vezeridis MP, Avradopoulos KA, et al. Repeat hepatic resection for recurrent colorectal cancer. World J Surg, 1997, 21(3): 292-296.
21
Tuttle TM, Curley SA, Roh MS. Repeat hepatic resection as effective treatment of recurrent colorectal liver metastases. Ann Surg Oncol, 1997, 4(2): 125-130.
22
Muratore A, Polastri R, Bouzari H, et al. Repeat hepatectomy for colorectal liver metastases: a worthwhile operation? J Surg Oncol, 2001, 76(2): 127-132.
23
Taschieri AM, Elli M, Vignati GA, et al. Repeated liver resection for recurrent metastases from colorectal cancer. Hepatogastroenterology, 2003, 50(50): 472-474.
24
Zacharias T, Jaeck D, Oussoultzoglou E, et al. First and repeat resection of colorectal liver metastases in elderly patients. Ann Surg, 2004, 240(5): 858-865.
25
Hamy A, Bennouna J, Heymann MF, et al. Repeat hepatectomy for colorectal liver metastases. Int Surg, 2005, 90(4): 189-197.
[1] 袁庆港, 刘理想, 张亮, 周世振, 高波, 丁超, 管文贤. 尿素-肌酐比值(UCR)可预测结直肠癌患者术后的长期预后[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 506-509.
[2] 艾贵生, 杨健, 蒋文涛. 肝移植治疗不可切除结直肠癌肝转移的研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(03): 174-180.
[3] 陈樽, 王平, 金华, 周美玲, 李青青, 黄永刚. 肌肉减少症预测结直肠癌术后切口疝发生的应用研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 639-644.
[4] 宋华传, 季鹏, 姚焕章, 王永帅, 张珅瑜, 宋瑞鹏, 王继洲. 腹腔镜肝切除术联合微波消融治疗多发性结直肠癌肝转移[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(04): 222-226.
[5] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[6] 赵泽云, 李建男, 王旻. 中性粒细胞胞外诱捕网在结直肠癌中的研究进展[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 524-528.
[7] 张金珠, 梅世文, 孙金峰, 胡刚, 邱文龙, 李国利, 汪欣, 王锡山, 汤坚强. 原发结直肠癌超系膜切除术后患者的生存危险因素分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(03): 197-204.
[8] 顾纪明, 蒋晖, 金留根, 钱程佳, 陈柏, 谢立飞. 腹腔镜辅助结肠次全切除术治疗同时性多原发结直肠癌的应用体会[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(02): 153-157.
[9] 王国强, 张纲, 唐建坡, 张玉国, 杨永江. LINC00839 调节miR-17-5p/WEE1 轴对结直肠癌细胞增殖、凋亡和迁移的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 491-499.
[10] 孙晗, 于冰, 武侠, 周熙朗. 基于循环肿瘤DNA 甲基化的结直肠癌筛查预测模型的构建与验证[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 500-506.
[11] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[12] 高静, 夏婷婷. 血清乳酸脱氢酶、中性粒细胞/淋巴细胞比值、血浆纤维蛋白原/前白蛋白比值对晚期结直肠癌患者姑息化疗效果与不良反应的评价[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(03): 203-207.
[13] 焦莉莉, 周芊池, 凌梦芸, 魏红玲, 徐缨. 血清SAA、CA19-9结合超声内镜对结直肠癌术前分期的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(02): 146-150.
[14] 朱菡, 卓士超, 吴迪, 朱雅楠, 韩佳欣. 术前血浆纤维蛋白原、血脂水平及MMR表达与结直肠癌病理特点及预后的相关性[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(02): 141-145.
[15] 王湛, 李文坤, 杨奕, 徐芳, 周敏思, 苏珈仪, 王亚丹, 吴静. 炎症指标在早发性结直肠肿瘤中的应用[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 802-810.
阅读次数
全文


摘要